Utilization of exacerbation-related drugs by COPD patients with Arg16Gly polymorphism of ADRB2 gene
K. Dmytriiev (Vinnitsya, Ukraine), Y. Mostovoy (Vinnitsya, Ukraine), N. Slepchenko (Vinnitsya, Ukraine), Y. Smereka (Vinnitsya, Ukraine), D. Dmytriiev (Vinnitsya, Ukraine), K. Dmytriieva (Vinnitsya, Ukraine)
Source: International Congress 2022 – COPD management: comorbidities, cohorts and real-world studies
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Dmytriiev (Vinnitsya, Ukraine), Y. Mostovoy (Vinnitsya, Ukraine), N. Slepchenko (Vinnitsya, Ukraine), Y. Smereka (Vinnitsya, Ukraine), D. Dmytriiev (Vinnitsya, Ukraine), K. Dmytriieva (Vinnitsya, Ukraine). Utilization of exacerbation-related drugs by COPD patients with Arg16Gly polymorphism of ADRB2 gene. 2112
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|